As healthcare systems in Europe shift towards value-based approaches in response to ageing populations and increased budget pressures, pharma companies need to show that they deliver value to patients.
Value-based healthcare (VBHC) is an approach that focuses on delivering high-quality outcomes to patients while considering the efficient use of healthcare resources. But it is not a miracle cure, and it requires cross-stakeholder collaboration.
So, you need to first do an internal and external readiness scan to assess feasibility. To this end CELforPharma faculty members Dr. Silvia Rohr & Mark Tolboom from the Value-based Healthcare for Pharma: Why – When – How? course, have developed a short assessment tool.